Patents by Inventor Paul Fisch

Paul Fisch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for identifying ?T-cell (or ?T-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective response
    Patent number: 11166984
    Abstract: The present invention relates to a method for identifying ?T-cell (or ?T-cell) receptors chains or parts thereof that mediate an anti-tumor or anti-infection response by identifying amino acid sequences comprising ?T-cells (or ?T-cell) receptors chains or parts thereof that are shared between different donors.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: November 9, 2021
    Assignees: UMC UTRECHT HOLDING B.V., Gadeta B.V., Albert-Ludwigs-Universität Freiburg
    Inventors: Jürgen Herbert Ernst Kuball, Anke Janssen, Dennis Beringer, Paul Fisch, Jose Alberto Villacorta Hidalgo
  • Novel method for identifying deltaT-cell (or gammaT-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective response
    Publication number: 20210177901
    Abstract: The present invention relates to a method for identifying ?T-cell (or ?T-cell) receptors chains or parts thereof that mediate an anti-tumor or anti-infection response by identifying amino acid sequences comprising ?T-cells (or ?T-cell) receptors chains or parts thereof that are shared between different donors.
    Type: Application
    Filed: December 17, 2020
    Publication date: June 17, 2021
    Applicants: UMC Utrecht Holding B.V., Gadeta B.V., Albert-Ludwigs-Universität Freiburg
    Inventors: Jürgen Herbert Ernst Kuball, Anke Janssen, Dennis Beringer, Paul Fisch, Jose Alberto Villacorta Hidalgo
  • Novel Method for Identifying DeltaT-Cell (or GammaT-Cell) Receptor Chains or Parts Thereof that Mediate an Anti-Tumour or an Anti-Infective Response
    Publication number: 20190209613
    Abstract: The present invention relates to a method for identifying ?T-cell (or ?T-cell) receptors chains or parts thereof that mediate an anti-tumor or anti-infection response by identifying amino acid sequences comprising ?T-cells (or ?T-cell) receptors chains or parts thereof that are shared between different donors.
    Type: Application
    Filed: December 10, 2018
    Publication date: July 11, 2019
    Inventors: Jürgen Herbert Ernst Kuball, Anke Janssen, Dennis Beringer, Paul Fisch, Jose Alberto Villacorta Hidalgo
  • Process for preparing dendritic cells, cells thus produced and containers for carrying out this process
    Patent number: 5866115
    Abstract: Dendritic cells are of interest therapeutically as antigen-presenting cells. A process is disclosed in which peripheral blood cells are first isolated and the CD 34 antigen-expressing blood progenitor cells which they contain are then enriched. These enriched cells are expanded ex-vivo using a combination of haematopoietic growth factors and cytokines. Over a period of 10-20 days, they give rise, in particular to dendritic cells which, where appropriate, can be purified still further. These cells are functionally active with regard to the ability to present antigen.
    Type: Grant
    Filed: October 11, 1996
    Date of Patent: February 2, 1999
    Assignee: Klinikum Der Albert-Ludwigs-Universitat Freiburg
    Inventors: Lothar Kanz, Wolfram Brugger, Reinhard Henschler, Gabriele Kohler, Hans-Eckart Schaefer, Albrecht Lindemann, Roland Mertelsmann, Andreas Mackensen, Paul Fisch, Birgit Herbst